Patients who have had treatment for a choroidal melanoma with radiation plaque brachytherapy will sometimes go on to develop retinal problems secondary to the radiation exposure which was needed to sterilize their tumor. This is called radiation retinopathy. These retinal problems can manifest as an increased thickness of the retina and/or intraretinal and subretinal fluid [..] Read More…
Retinoblastoma (RB) is the most common eye cancer in children, affecting approximately 8,000 of them each year. In developed countries like the United States, the survival rate reaches beyond an astounding 96%, with early diagnosis and treatment being key to saving a patient’s life and sight. However, this incidence rate is higher in developing countries, [..] Read More…
Whether scrolling through the latest Twitter trends or clearing out your inbox, if you’ve browsed the internet within this past week, the chances are that you have received an influx of emails regarding privacy policy updates from some of your most-frequented websites. You may be wondering: what do all of these updates mean, and should [..] Read More…
In our previous blog, we unveiled Dr. Finger’s Results page, the first public database of its kind to report a doctor’s treatment outcomes. With the power of the world-wide-web at our fingertips, it is now easier than ever to browse for healthcare options. Search engines, with the simple press of a button, are able to [..] Read More…
With 87,110 diagnoses estimated to be made in 2018 for U.S. Americans, skin cancer, particularly a melanoma, is the most frequently diagnosed cancer in the United States. Ocular melanomas, however, remain uncommonly diagnosed, affecting just six in every one million people a year. Given the extreme rarity of ocular melanomas, doctors and researchers were [..] Read More…
As you may have heard in our previous blog, the American Academy of Ophthalmology (AAO) 2017 Meeting in New Orleans, Louisiana was attended by noteworthy fellowship alumni from the Eye Cancer Foundation, as well as founder and executive director of the ECF, Dr. Paul T. Finger. Held from November 11th to 14th, AAO took [..] Read More…
After several successful meetings throughout the close of 2017, The Ocular Tumor Support Group is back in session! Do you have feelings of loss, stress, anxiety, and/or depression? To be sure, these are all possible experiences people have as they begin to adjust and live with a cancer diagnosis — but why endure it alone? [..] Read More…
Right alongside cancers of the breast and lung, skin cancer exists as a well-known cancer afflicting U.S. Americans. The history of cancer study has lead to the identification of over 200 types of the disease, and skin cancer is the most commonly diagnosed of them, affecting more than 1 million Americans a year. Information on [..] Read More…
At the close of 2017, The Eye Cancer Foundation promised its supporters to continue the momentum of the tremendous strides made throughout the year, and indeed it has with yet another Eye Cancer Foundation Ophthalmic Oncology Fellowship thus completed. Meet the ECF’s latest Fellowship alumnus: Abhilasha. Abhilasha Maheshwari, MBBS, hails from the bustling northern city [..] Read More…
The New York Eye Cancer Center and the Eye Cancer Foundation were quite actively represented at the 2017 American Association of Ophthalmic Oncologists and Pathologists (AAOOP) Annual Meeting. The meeting was held on Friday, November 10, 2017 at the Hampton Inn & Suites Convention Center, located in the vibrant city of New Orleans, Louisiana, and [..] Read More…
"Very well treated by Dr. Finger. He explained everything I needed to know about my issue with detail and attention, putting me at ease and giving me confidence to handle this problem for the rest of my life.”
– N.N.
>
>
